731015-35-3

Upstream product

• 6393-40-4 4-Amino 3-nitro-benzonitrile 
• 123342-40-5 methyl 2-(4-hydroxyphenyl)-2-methylpropanoate 
• 5351-07-5 2-(4-methoxy-phenyl)-2-methyl-propionitrile 
• 29913-51-7 2-methyl-2-(p-hydroxyphenyl)-propionic acid 
• 2955-46-6 2-(4-methoxyphenyl)-2-methylpropanoic acid 
• 529-28-2 4-iodoanisol 
• 885461-10-9 C₇H₆ClIO₃S 
• 718603-63-5 N-tert-butyl-3-iodo-4-methoxybenzenesulfonamide 
• 731015-61-5 methyl 2-[5'-(N-tert-butylsulfamoyl)-5-formyl-6,2'-dimethoxybi-phenyl-3-yl]-2-methylpropionate 
• 731016-03-8 methyl 2-(3-bromo-5-formyl-4-methoxyphenyl)-2-methyl-propionate 
• 731016-02-7 N-tert-butyl-2-methoxy-5-(benzenesulfonamido)boronic acid 
• 731015-45-5 methyl 2-(3-bromo-5-formyl-4-hydroxy-phenyl)-2-methyl-propionate 
• 731015-44-4 methyl 2-(3-formyl-4-hydroxyphenyl)-2-methylpropanoate 
• 74138-37-7 4-amino-3-nitrobenzamidine monohydrochloride 

Downstream Products

• 871822-60-5 (2S)-{2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]-2-methylpropionylamino}succinamide 

Relevant academic research and scientific papers

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders

2-'5-(5-CARBAMIMIDOYL-1H-HETEROARYL)-6-HYDROXYBIPHENYL-3-YL!- CARBOXYLIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders. Processes for preparing these inhibitors are also disclosed.